Doctor of Optometry Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Amy Lee

Optometrist New York, NY Doctor of Optometry

NPI 1376742478 CMS profile 198888

33 W 42Nd St, New York, NY 10036

Open in the dashboard

General payments

$5,323

193 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Amy Lee of New York, NY is reported in the CMS Open Payments database as having received $5,323 across 193 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 94th percentile of Optometrist profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $713 26
2024 General $1,060 42
2023 General $1,589 56
2022 General $387 14
2021 General $401 17
2020 General $255 15
2019 General $918 23

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Amy Lee
  • Optometrist median
  • Middle half of Optometrist
  • National median

In program year 2025, general payments to Amy Lee were reported at $713. Among 35,373 Optometrist profiles paid that year, the median was $204 and the middle half received between $87 and $464.

Show as a table
Year Amy Lee Optometrist median Middle half National median
2019 $918 $159 $67–$371 $163
2020 $255 $72 $29–$165 $114
2021 $401 $125 $46–$292 $132
2022 $387 $162 $66–$374 $149
2023 $1,589 $177 $72–$406 $160
2024 $1,060 $188 $77–$427 $164
2025 $713 $204 $87–$464 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Alcon Vision LLC $1,588 44 payments
  2. Sun Pharmaceutical Industries Inc. $868 47 payments
  3. Oyster Point Pharma, Inc. $802 29 payments
  4. AbbVie, Inc. $359 17 payments
  5. Bausch & Lomb Americas Inc. $239 11 payments
  6. Novartis Pharmaceuticals Corporation $210 13 payments
  7. CooperVision Inc. $209 2 payments
  8. Johnson & Johnson Vision Care, Inc. $200 2 payments
  9. Aerie Pharmaceuticals, Inc. $173 4 payments
  10. Johnson & Johnson Surgical Vision, Inc. $158 5 payments
  11. Other $515 19 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Food and Beverage $5,323 193 payments
Products named General payments · program years 2019–2025
  1. Cequa $758 41 payments
  2. DAILIES $677 12 payments
  3. Precision 1 $548 12 payments
  4. TYRVAYA Dry Eye $396 14 payments
  5. XIIDRA $339 19 payments
  6. TYRVAYA Dry eyes $293 11 payments
  7. MyDay Contact Lens $209 2 payments
  8. Ryzumvi $204 7 payments
  9. LUMIGAN $202 8 payments
  10. Acuvue $200 2 payments
  11. Other $2,573 98 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Records

193 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Optometrist in New York

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record